Evidence map›Paper›PMID 38887396›Full record

ReviewEXCLI journal2024

Recent advances, challenges and updates on the development of therapeutics for malaria.

Rimmy Nandal, Davinder Kumar, Navidha Aggarwal, Virender Kumar, Balasubramanian Narasimhan, Rakesh Kumar Marwaha, Prabodh Chander Sharma, Surender Kumar, Nitin Bansal, Hitesh Chopra and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in EXCLI journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rimmy NandalShri Baba MastNath Institute of Pharmaceutical Sciences and Research, Baba Mast Nath University, Asthal Bohar, Rohtak-124001, Haryana, India.
Davinder KumarCollege of Pharmacy, PGIMS University of Health Sciences, Rohtak-124001, Haryana, India.
Navidha AggarwalMM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala 133207, India.
Virender KumarCollege of Pharmacy, PGIMS University of Health Sciences, Rohtak-124001, Haryana, India.
Balasubramanian NarasimhanDepartment of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001 Haryana, India.
Rakesh Kumar MarwahaDepartment of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001 Haryana, India.
Prabodh Chander SharmaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi 110017, India.
Surender KumarDepartment of Chemistry, Chaudhary Bansi Lal University, Bhiwani-127021, India.
Nitin BansalDepartment of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani-127021, Haryana, India.
Hitesh ChopraDepartment of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai - 602105, Tamil Nadu, India.
Aakash DeepDepartment of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani-127021, Haryana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria has developed as a serious worldwide health issue as a result of the introduction of resistant

Indexed as

antimalarialsartefenomelcipargaminclinical trialsmalariatafenoquine

Identifiers

PMID38887396
PMCPMC11180964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.